Hospital-based home care for children with cancer: Feasibility and psychosocial impact on children and their families

被引:37
作者
Hansson, Helena [1 ]
Kjaergaard, Hanne [1 ]
Johansen, Christoffer [2 ]
Hallstroem, Inger [3 ]
Christensen, Jane [4 ]
Madsen, Marianne [5 ]
Schmiegelow, Kjeld [5 ]
机构
[1] Rigshosp, Res Unit Womens & Childrens Hlth, Juliane Marie Ctr Women Children & Reprod, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark
[2] Danish Canc Soc, Dept Psychosocial Canc Res, Inst Canc Epidemiol, Copenhagen, Denmark
[3] Lund Univ, Fac Med, Dept Hlth Sci, Lund, Sweden
[4] Danish Canc Soc, Dept Stat & Epidemiol, Inst Canc Epidemiol, Copenhagen, Denmark
[5] Rigshosp, Dept Paediat & Adolescent Med, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark
基金
瑞典研究理事会;
关键词
chemotherapy; home care; pediatric oncology; quality of life; QUALITY-OF-LIFE; PEDIATRIC CANCER; BRAIN-TUMORS; CHEMOTHERAPY; ONCOLOGY; FATIGUE; SAFETY;
D O I
10.1002/pbc.24474
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background To assess the feasibility and psychosocial impact of a hospital-based home care (HBHC) program for children with cancer. Procedure A HBHC program was carried out with 51 children (018 years) with cancer to assess its feasibility in terms of satisfaction, care preferences, safety, and cost. A controlled trial was conducted to assess children's health-related quality of life (HRQOL) using the parent-reported and self-reported PedsQL Generic Core Scale and PedsQL Cancer Module, and the psychosocial impact on the family by PedsQL Family Impact Module comprising a subsample of 28 children and 43 parents in the home care group, and 47 children and 66 parents receiving standard hospital care. Results All parents in the HBHC program were satisfied and preferred home care. There were no serious adverse events associated with HBHC, and costs did not increase. When adjusting for age, gender, diagnosis and time since diagnosis, we found significant higher HRQOL scores in parent-reported physical health (P=0.04; 95% confidence interval (CI): 0.219.5) and worry (P=0.04; 95% CI: 0.420.6) in the home-care group indicating better physical health and less worry for children in the home-care group. No significant difference was found in the Family Impact Module. Conclusion This study indicates that HBHC is a feasible alternative to hospital care for children with cancer, and is greatly preferred by parents. Specific aspects of children's HRQOL may be improved with HBHC and the psychosocial burden on the family does not increase. Pediatr Blood Cancer 2013; 60: 865872. (c) 2013 Wiley Periodicals, Inc.
引用
收藏
页码:865 / 872
页数:8
相关论文
共 30 条
[1]  
[Anonymous], COCHRANE DATABASE SY
[2]  
Bjork Maria, 2009, J Pediatr Nurs, V24, P423, DOI 10.1016/j.pedn.2008.01.082
[3]  
CLOSE P, 1995, PEDIATRICS, V95, P896
[4]   Measuring quality of life [J].
Eiser, Christine ;
Jenney, Meriel .
ARCHIVES OF DISEASE IN CHILDHOOD, 2007, 92 (04) :348-350
[5]  
Frierdich Sharon, 2003, J Pediatr Oncol Nurs, V20, P252, DOI 10.1177/1043454203254052
[6]   Hospital-based home care for children with cancer: a qualitative exploration of family members' experiences in Denmark [J].
Hansson, H. ;
Kjaergaard, H. ;
Schmiegelow, K. ;
Hallstrom, I. .
EUROPEAN JOURNAL OF CANCER CARE, 2012, 21 (01) :59-66
[7]   Hospital-Based Home Care for Children With Cancer [J].
Hansson, Helena ;
Hallstrom, Inger ;
Kjaergaard, Hanne ;
Johansen, Christoffer ;
Schmiegelow, Kjeld .
PEDIATRIC BLOOD & CANCER, 2011, 57 (03) :369-377
[8]  
Hinds Pamela S, 2006, Oncol Nurs Forum, V33, P23, DOI 10.1188/06.ONF.S1.23-29
[9]   Health-related quality of life in adolescents at the time of diagnosis with osteosarcoma or acute myeloid leukemia [J].
Hinds, Pamela S. ;
Billups, Catherine A. ;
Cao, Xueyuan ;
Gattuso, Jami S. ;
Burghen, Elizabeth ;
West, Nancy ;
Rubnitz, Jeffrey E. ;
Daw, Najat C. .
EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2009, 13 (03) :156-163
[10]   Economic impact with home delivery of chemotherapy to pediatric oncology patients [J].
Holdsworth, MT ;
Raisch, DW ;
Chavez, CM ;
Duncan, MH ;
Parasuraman, TV ;
Cox, FM .
ANNALS OF PHARMACOTHERAPY, 1997, 31 (02) :140-148